Rebecca Mosher

As SVP, Translational Medicine, Beccy joined Kymera to provide strategic oversight and tactical support for translational activities across all clinical stage and discovery programs. She has worked in the industry setting for more than 20 years. Prior to joining Kymera, she was Vice President of Translational Medicine at Mersana Therapeutics. She previously held positions of increasing responsibility in translational research and molecular pathology at Novartis, Vertex, and Millennium. Beccy graduated from Harvard College and received her MD from Columbia University. Her residency and fellowship training were in Anatomic and Clinical Pathology, and Cytopathology at Brigham and Women’s Hospital and Boston Medical Center. Before joining industry, Beccy practiced as a pathologist in the Boston area.